The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A comparison between next-generation sequencing and ASO-qPCR for minimal residual disease detection in multiple myeloma.
Hiroyuki Takamatsu
No relevant relationships to disclose
Ryoichi Murata
No relevant relationships to disclose
Jianbiao Zheng
Employment or Leadership Position - Sequenta
Stock Ownership - Sequenta
Research Funding - Sequenta
Martin Moorhead
Employment or Leadership Position - Sequenta
Stock Ownership - Sequenta
Research Funding - Sequenta
Yasushi Terasaki
No relevant relationships to disclose
Takashi Yoshida
No relevant relationships to disclose
Malek Faham
Employment or Leadership Position - Sequenta
Stock Ownership - Sequenta
Research Funding - Sequenta
Shinji Nakao
No relevant relationships to disclose